The words hit me like a punch in the stomach. I felt all the blood drain from my face and the air seep out of my lungs. Until ...
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...
A study investigating GSK’s investigational herpes simplex virus (HSV) vaccine candidate failed to meet its primary efficacy endpoint.
Immvira Group Co.’s oncolytic herpes simplex virus product, MVR-T3011, showed early efficacy via intravesical administration in patients with high-risk BCG-failure non-muscle invasive bladder cancer.
While they can heal naturally, preventing a fever blister from recurring should be a priority for anyone who has experienced ...